Lv7277
5000 积分 2021-08-09 加入
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
30天前
已完结
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
30天前
已完结
Prevalence, Penetrance, and Phenotypic Manifestation of Cardiomyopathy-Associated Genetic Variants in the General Population: Insights from a Mayo Clinic Biobank Study
1个月前
已完结
Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathy
1个月前
已完结
Exploration of Neurodegenerative Diseases Using Long-Read Sequencing and Optical Genome Mapping Technologies
1个月前
已关闭
Follow the LINE: A novel case of dilated cardiomyopathy caused by a LINE-1 insertion in the TTN gene
2个月前
已完结
Genetic and clinical heterogeneity of ferroportin disease
3个月前
已完结
MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway
4个月前
已完结
Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation
5个月前
已关闭
Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation
5个月前
已完结
皖公网安备34019202002308
